nodes	percent_of_prediction	percent_of_DWPC	metapath
Clavulanate—Cystitis haemorrhagic—Bleomycin—skin cancer	0.0877	0.0877	CcSEcCtD
Clavulanate—Induration—Imiquimod—skin cancer	0.0554	0.0554	CcSEcCtD
Clavulanate—Induration—Bleomycin—skin cancer	0.0393	0.0393	CcSEcCtD
Clavulanate—Hypokalaemia—Vismodegib—skin cancer	0.031	0.031	CcSEcCtD
Clavulanate—Swelling—Imiquimod—skin cancer	0.0204	0.0204	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Vemurafenib—skin cancer	0.019	0.019	CcSEcCtD
Clavulanate—Eosinophilia—Vemurafenib—skin cancer	0.018	0.018	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Vemurafenib—skin cancer	0.0161	0.0161	CcSEcCtD
Clavulanate—Pain—Vismodegib—skin cancer	0.0143	0.0143	CcSEcCtD
Clavulanate—Erythema multiforme—Vemurafenib—skin cancer	0.0138	0.0138	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Imiquimod—skin cancer	0.0137	0.0137	CcSEcCtD
Clavulanate—Haemoglobin—Imiquimod—skin cancer	0.0125	0.0125	CcSEcCtD
Clavulanate—Thrombophlebitis—Temozolomide—skin cancer	0.0124	0.0124	CcSEcCtD
Clavulanate—Haemorrhage—Imiquimod—skin cancer	0.0124	0.0124	CcSEcCtD
Clavulanate—Pruritus—Vismodegib—skin cancer	0.0119	0.0119	CcSEcCtD
Clavulanate—Erythema multiforme—Imiquimod—skin cancer	0.0118	0.0118	CcSEcCtD
Clavulanate—Diarrhoea—Vismodegib—skin cancer	0.0115	0.0115	CcSEcCtD
Clavulanate—Thrombophlebitis—Fluorouracil—skin cancer	0.0115	0.0115	CcSEcCtD
Clavulanate—Swelling—Fluorouracil—skin cancer	0.0113	0.0113	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Dactinomycin—skin cancer	0.0107	0.0107	CcSEcCtD
Clavulanate—Vomiting—Vismodegib—skin cancer	0.0107	0.0107	CcSEcCtD
Clavulanate—Rash—Vismodegib—skin cancer	0.0106	0.0106	CcSEcCtD
Clavulanate—Dermatitis—Vismodegib—skin cancer	0.0106	0.0106	CcSEcCtD
Clavulanate—Anaphylactic shock—Vemurafenib—skin cancer	0.0104	0.0104	CcSEcCtD
Clavulanate—Nausea—Vismodegib—skin cancer	0.00996	0.00996	CcSEcCtD
Clavulanate—Hypokalaemia—Temozolomide—skin cancer	0.0098	0.0098	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Temozolomide—skin cancer	0.0097	0.0097	CcSEcCtD
Clavulanate—Convulsion—Imiquimod—skin cancer	0.00938	0.00938	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.0091	0.0091	CcSEcCtD
Clavulanate—Haemoglobin—Bleomycin—skin cancer	0.00888	0.00888	CcSEcCtD
Clavulanate—Haemorrhage—Bleomycin—skin cancer	0.00883	0.00883	CcSEcCtD
Clavulanate—Eosinophilia—Fluorouracil—skin cancer	0.00849	0.00849	CcSEcCtD
Clavulanate—Thrombophlebitis—Docetaxel—skin cancer	0.00828	0.00828	CcSEcCtD
Clavulanate—Hepatitis—Dactinomycin—skin cancer	0.00824	0.00824	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.00823	0.00823	CcSEcCtD
Clavulanate—Swelling—Docetaxel—skin cancer	0.00812	0.00812	CcSEcCtD
Clavulanate—Erythema multiforme—Dactinomycin—skin cancer	0.00779	0.00779	CcSEcCtD
Clavulanate—Hypersensitivity—Vemurafenib—skin cancer	0.00763	0.00763	CcSEcCtD
Clavulanate—Pain—Imiquimod—skin cancer	0.00755	0.00755	CcSEcCtD
Clavulanate—Haemoglobin—Temozolomide—skin cancer	0.00749	0.00749	CcSEcCtD
Clavulanate—Haemorrhage—Temozolomide—skin cancer	0.00745	0.00745	CcSEcCtD
Clavulanate—Hepatitis—Temozolomide—skin cancer	0.00745	0.00745	CcSEcCtD
Clavulanate—Pruritus—Vemurafenib—skin cancer	0.00733	0.00733	CcSEcCtD
Clavulanate—Diarrhoea—Vemurafenib—skin cancer	0.00709	0.00709	CcSEcCtD
Clavulanate—Erythema multiforme—Temozolomide—skin cancer	0.00705	0.00705	CcSEcCtD
Clavulanate—Urticaria—Imiquimod—skin cancer	0.00702	0.00702	CcSEcCtD
Clavulanate—Haemoglobin—Fluorouracil—skin cancer	0.0069	0.0069	CcSEcCtD
Clavulanate—Leukopenia—Bleomycin—skin cancer	0.00688	0.00688	CcSEcCtD
Clavulanate—Haemorrhage—Fluorouracil—skin cancer	0.00687	0.00687	CcSEcCtD
Clavulanate—Vomiting—Vemurafenib—skin cancer	0.00659	0.00659	CcSEcCtD
Clavulanate—Rash—Vemurafenib—skin cancer	0.00653	0.00653	CcSEcCtD
Clavulanate—Dermatitis—Vemurafenib—skin cancer	0.00653	0.00653	CcSEcCtD
Clavulanate—Hypersensitivity—Imiquimod—skin cancer	0.00651	0.00651	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.00645	0.00645	CcSEcCtD
Clavulanate—Leukopenia—Dactinomycin—skin cancer	0.00642	0.00642	CcSEcCtD
Clavulanate—Anaphylactic shock—Bleomycin—skin cancer	0.00628	0.00628	CcSEcCtD
Clavulanate—Pruritus—Imiquimod—skin cancer	0.00625	0.00625	CcSEcCtD
Clavulanate—Nausea—Vemurafenib—skin cancer	0.00615	0.00615	CcSEcCtD
Clavulanate—Thrombocytopenia—Bleomycin—skin cancer	0.00615	0.00615	CcSEcCtD
Clavulanate—Diarrhoea—Imiquimod—skin cancer	0.00604	0.00604	CcSEcCtD
Clavulanate—Leukopenia—Temozolomide—skin cancer	0.00581	0.00581	CcSEcCtD
Clavulanate—Thrombocytopenia—Dactinomycin—skin cancer	0.00573	0.00573	CcSEcCtD
Clavulanate—Convulsion—Temozolomide—skin cancer	0.00562	0.00562	CcSEcCtD
Clavulanate—Vomiting—Imiquimod—skin cancer	0.00562	0.00562	CcSEcCtD
Clavulanate—Rash—Imiquimod—skin cancer	0.00557	0.00557	CcSEcCtD
Clavulanate—Dermatitis—Imiquimod—skin cancer	0.00557	0.00557	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.00547	0.00547	CcSEcCtD
Clavulanate—Pain—Bleomycin—skin cancer	0.00537	0.00537	CcSEcCtD
Clavulanate—Leukopenia—Fluorouracil—skin cancer	0.00535	0.00535	CcSEcCtD
Clavulanate—Anaphylactic shock—Temozolomide—skin cancer	0.00529	0.00529	CcSEcCtD
Clavulanate—Nausea—Imiquimod—skin cancer	0.00525	0.00525	CcSEcCtD
Clavulanate—Thrombocytopenia—Temozolomide—skin cancer	0.00518	0.00518	CcSEcCtD
Clavulanate—Convulsion—Fluorouracil—skin cancer	0.00518	0.00518	CcSEcCtD
Clavulanate—Pain—Dactinomycin—skin cancer	0.00501	0.00501	CcSEcCtD
Clavulanate—Urticaria—Bleomycin—skin cancer	0.00499	0.00499	CcSEcCtD
Clavulanate—Haemoglobin—Docetaxel—skin cancer	0.00498	0.00498	CcSEcCtD
Clavulanate—Haemorrhage—Docetaxel—skin cancer	0.00496	0.00496	CcSEcCtD
Clavulanate—Hepatitis—Docetaxel—skin cancer	0.00496	0.00496	CcSEcCtD
Clavulanate—Anaphylactic shock—Fluorouracil—skin cancer	0.00488	0.00488	CcSEcCtD
Clavulanate—Thrombocytopenia—Fluorouracil—skin cancer	0.00478	0.00478	CcSEcCtD
Clavulanate—Erythema multiforme—Docetaxel—skin cancer	0.00469	0.00469	CcSEcCtD
Clavulanate—Hypersensitivity—Bleomycin—skin cancer	0.00462	0.00462	CcSEcCtD
Clavulanate—Pain—Temozolomide—skin cancer	0.00453	0.00453	CcSEcCtD
Clavulanate—Pruritus—Bleomycin—skin cancer	0.00444	0.00444	CcSEcCtD
Clavulanate—Hypersensitivity—Dactinomycin—skin cancer	0.00431	0.00431	CcSEcCtD
Clavulanate—Urticaria—Temozolomide—skin cancer	0.00421	0.00421	CcSEcCtD
Clavulanate—Pain—Fluorouracil—skin cancer	0.00417	0.00417	CcSEcCtD
Clavulanate—Diarrhoea—Dactinomycin—skin cancer	0.00401	0.00401	CcSEcCtD
Clavulanate—Vomiting—Bleomycin—skin cancer	0.00399	0.00399	CcSEcCtD
Clavulanate—Rash—Bleomycin—skin cancer	0.00396	0.00396	CcSEcCtD
Clavulanate—Dermatitis—Bleomycin—skin cancer	0.00395	0.00395	CcSEcCtD
Clavulanate—Hypersensitivity—Temozolomide—skin cancer	0.0039	0.0039	CcSEcCtD
Clavulanate—Urticaria—Fluorouracil—skin cancer	0.00388	0.00388	CcSEcCtD
Clavulanate—Leukopenia—Docetaxel—skin cancer	0.00386	0.00386	CcSEcCtD
Clavulanate—Pruritus—Temozolomide—skin cancer	0.00375	0.00375	CcSEcCtD
Clavulanate—Convulsion—Docetaxel—skin cancer	0.00374	0.00374	CcSEcCtD
Clavulanate—Nausea—Bleomycin—skin cancer	0.00373	0.00373	CcSEcCtD
Clavulanate—Vomiting—Dactinomycin—skin cancer	0.00372	0.00372	CcSEcCtD
Clavulanate—Rash—Dactinomycin—skin cancer	0.00369	0.00369	CcSEcCtD
Clavulanate—Diarrhoea—Temozolomide—skin cancer	0.00362	0.00362	CcSEcCtD
Clavulanate—Hypersensitivity—Fluorouracil—skin cancer	0.00359	0.00359	CcSEcCtD
Clavulanate—Anaphylactic shock—Docetaxel—skin cancer	0.00352	0.00352	CcSEcCtD
Clavulanate—Nausea—Dactinomycin—skin cancer	0.00348	0.00348	CcSEcCtD
Clavulanate—Pruritus—Fluorouracil—skin cancer	0.00345	0.00345	CcSEcCtD
Clavulanate—Thrombocytopenia—Docetaxel—skin cancer	0.00345	0.00345	CcSEcCtD
Clavulanate—Vomiting—Temozolomide—skin cancer	0.00337	0.00337	CcSEcCtD
Clavulanate—Rash—Temozolomide—skin cancer	0.00334	0.00334	CcSEcCtD
Clavulanate—Diarrhoea—Fluorouracil—skin cancer	0.00334	0.00334	CcSEcCtD
Clavulanate—Dermatitis—Temozolomide—skin cancer	0.00334	0.00334	CcSEcCtD
Clavulanate—Nausea—Temozolomide—skin cancer	0.00314	0.00314	CcSEcCtD
Clavulanate—Vomiting—Fluorouracil—skin cancer	0.0031	0.0031	CcSEcCtD
Clavulanate—Rash—Fluorouracil—skin cancer	0.00308	0.00308	CcSEcCtD
Clavulanate—Dermatitis—Fluorouracil—skin cancer	0.00307	0.00307	CcSEcCtD
Clavulanate—Pain—Docetaxel—skin cancer	0.00301	0.00301	CcSEcCtD
Clavulanate—Nausea—Fluorouracil—skin cancer	0.0029	0.0029	CcSEcCtD
Clavulanate—Hypersensitivity—Docetaxel—skin cancer	0.00259	0.00259	CcSEcCtD
Clavulanate—Pruritus—Docetaxel—skin cancer	0.00249	0.00249	CcSEcCtD
Clavulanate—Diarrhoea—Docetaxel—skin cancer	0.00241	0.00241	CcSEcCtD
Clavulanate—Vomiting—Docetaxel—skin cancer	0.00224	0.00224	CcSEcCtD
Clavulanate—Rash—Docetaxel—skin cancer	0.00222	0.00222	CcSEcCtD
Clavulanate—Dermatitis—Docetaxel—skin cancer	0.00222	0.00222	CcSEcCtD
Clavulanate—Nausea—Docetaxel—skin cancer	0.00209	0.00209	CcSEcCtD
